SUPRA SDRM® is a novel synthetic, guided wound closure matrix,
built as a bimodal foam membrane structure for the management of
SUPRA SDRM® combines the benefits of the microporous structure
known from Suprathel® that builds a protective barrier allowing the wound to heal and additional large pores which were created to enable ingrowth of blood vessels.
SUPRA SDRM® is fully synthetic – no animal derived components – polylactic acid as the main component reduces the biologic risk and systemic inflammatory reactions. No preparation of SUPRA SDRM® matrix is necessary. When applied to the wound SUPRA SDRM® adheres well to the wound bed without the need for direct fixation. SUPRA SDRM® becomes translucent after the application allowing healthcare professionals to easily assess the wound healing.
SUPRA SDRM® is available in multiple sizes and can be trimmed to meet the patient’s needs.
SUPRA SDRM® is indicated for use in the management of:
- Pressure (stage I and IV) and venous Ulcers
- Partial thickness burns
- Ulcers caused by mixed vascular Etiologies
- Trauma wounds
- Venous stasis and diabetic ulcers
- Surgical wounds
- Partial and full thickness wounds
Packaging the different SUPRA SDRM® order sizes are:
|1 x 1 cm||1||310101-US|
|2 x 2 cm||1||310202-US|
|5.1 x 5.1 cm||1||310505-US|
|9 x 9 cm||1||310909-US|
|9 x 12 cm||1||310912-US|
|18 x 9 cm||1||311809-US|
|18 x 18 cm||1||311818-US|
Effective July 1, 2020 the HCPCS Workgroup created a new HCPCS code, C1849 for “Skin substitute, synthetic, resorbable, per square centimeter”. CMS has designated C1849 as a high cost skin substitute under the Medicare Outpatient Prospective Payment System.
Download reimbursement guide (short version).
OR CALL THE PMI CUSTOMER SERVICE AT 646 604 2771